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Background: The molybdenum cofactor (Moco) is an essential component of a
large family of enzymes involved in important transformations in carbon, nitrogen
and sulfur metabolism. The Moco biosynthetic pathway is evolutionarily conserved
and found in archaea, eubacteria and eukaryotes. In humans, genetic deficiencies
of enzymes involved in this pathway trigger an autosomal recessive and usually
deadly disease with severe neurological symptoms. The MoaC protein, together
with the MoaA protein, is involved in the first step of Moco biosynthesis.
Results: MoaC from Escherichia coli has been expressed and purified to
homogeneity and its crystal structure determined at 2 Å resolution. The enzyme is
organized into a tightly packed hexamer with 32 symmetry. The monomer consists
of an antiparallel, four-stranded β sheet packed against two long α helices, and its
fold belongs to the ferredoxin-like family. Analysis of structural and biochemical
data strongly suggests that the active site is located at the interface of two
monomers in a pocket that contains several strictly conserved residues. 
Conclusions: Asp128 in the putative active site appears to be important for
catalysis as its replacement with alanine almost completely abolishes protein
activity. The structure of the Asp128→Ala variant reveals substantial
conformational changes in an adjacent loop. In the human MoaC ortholog,
substitution of Thr182 with proline causes Moco deficiency, and the
corresponding substitution in MoaC severely compromises activity. This residue
is located near the N-terminal end of helix α4 at an interface between two
monomers. The MoaC structure provides a framework for the analysis of
additional dysfunctional mutations in the corresponding human gene.
Introduction
The molybdenum cofactor [1,2] (Moco) is an essential
component of a diverse group of enzymes that catalyze
important redox transformations in the global carbon,
nitrogen and sulfur cycles [1,3,4]. In humans, the cat-
alytic activities of three enzymes, sulfite oxidase, xan-
thine dehydrogenase and aldehyde oxidase, depend on
this cofactor. The cofactor consists of a mononuclear
molybdenum coordinated by the dithiolene moiety of a
family of tricyclic pyranopterin structures, the simplest of
which is commonly referred to as molybdopterin (MPT)
[1]. In the past few years, several crystal structures of
enzymes containing this cofactor have been determined
[5–8]. These initial structures provide a framework for
studying the four currently recognized families of
enzymes containing a pyranopterin cofactor [4]. As part of
our goal to characterize the enzymes involved in Moco
biosynthesis by protein crystallography, we have recently
reported the crystal structure of Escherichia coli MogA, a
protein involved in the later steps of molybdopterin
biosynthesis. MogA is the first protein in this pathway for
which a three-dimensional structure is available [9]. 
Moco deficiency causes a severe disease in humans that
usually results in premature death in early childhood and is
inherited as an autosomal recessive trait. Mutations in the
genes encoding the proteins involved in Moco biosynthesis
lead to loss of activity of the enzymes requiring this cofactor
in humans. The affected patients show severe neurological
abnormalities such as attenuated growth of the brain,
seizures and, frequently, dislocated ocular lenses. As these
symptoms are identical to those exhibited by patients suf-
fering from isolated sulfite oxidase deficiency, this enzyme
has been identified as the Moco-containing enzyme most
crucial for human health. Together, Moco deficiency and
sulfite oxidase deficiency have been diagnosed in more
than 100 individuals worldwide [10]. Recently, the first
mutations in a number of human genes encoding Moco
biosynthetic proteins have been identified [11–13]
(JL Johnson and KVR, unpublished data); among these are
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mutations in the gene encoding MOCS1B, the human
ortholog of the E. coli MoaC protein. To date, two
frameshift mutations and a point mutation at position 182 of
MOCS1B have been identified. As a consequence of the
point mutation, a conserved threonine (corresponding to
residue 117 in the E. coli protein) is replaced by a proline. 
Genes involved in Moco biosynthesis have been identi-
fied in eubacteria, archaea and eukaryotes. Although some
details of Moco biosynthesis are still unclear, the pathway
can be divided into three phases [14,15] as shown in
Figure 1a. In the first step a guanosine derivative, most
likely GTP, is converted into precursor Z. This aspect is
different from other pterin biosynthetic pathways, as C8
of the purine is inserted between the 2′ and 3′ ribose
carbon atoms during formation of precursor Z, rather than
being eliminated [16,17]. In E. coli, the MoaA and MoaC
proteins appear to be responsible for this rather elaborate
conversion, but the detailed aspects of the reactions cat-
alyzed by these enzymes and their actual substrates are
unknown. Interestingly, the homologous human proteins
are encoded by a highly unusual, bicistronic mRNA
[11,18,19]. The second step involves the transformation of
precursor Z into molybdopterin. This process generates
the dithiolene group responsible for coordination of the
molybdenum atom in the cofactor, and the reaction is cat-
alyzed by molybdopterin synthase, which in turn is acti-
vated by MoeB. The final step in the pathway is the
incorporation of metal into the apo cofactor. 
We describe here the purification, characterization and
high-resolution crystal structure of the E. coli MoaC
protein. The 161-residue protein is folded into a compact
molecule with α+β architecture. The protein is present as
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Structure
The Moco biosynthetic pathway and the role of MoaC. (a) Moco
biosynthesis in E. coli. In the first step, MoaA and MoaC are responsible
for the conversion of a guanosine derivative (GXP) into precursor Z. The
carbon atom at position 8 of the guanine is incorporated into precursor Z
as indicated by the asterisk. Besides the dithiolene sulfurs shown here,
additional ligands to the molybdenum are present in the mature cofactor,
and there are various dinucleotide forms of the cofactor. (b) Sequence
alignment of MoaC proteins from different species. From top to bottom,
MoaC from E. coli, Synechocystis sp., Pyrococcus abyssii, Arabidopsis
thaliana and Homo sapiens. Strictly conserved residues based on 18
MoaC sequences are highlighted in black; similar residues are shown
boxed. The sequences of Synechocystis sp., A. thaliana and human
MoaC are considerably longer than that of E. coli MoaC, and these
additional residues are not included. This alignment was generated with
the program ALSCRIPT [45]. Secondary structure elements of wild-type
MoaC, as determined with the program PROMOTIF [46], are indicated:
α helices are shown as cylinders and β strands as arrows.
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a tightly interacting hexamer in the crystal and is also
hexameric in solution. On the basis of the location of con-
served residues and site-directed mutagenesis studies,
we have assigned the putative active site. Biochemical
experiments have identified Asp128 as being critical for
activity and the crystal structure of an Asp128→Ala
(D128A) variant has been determined. The crystal struc-
ture of MoaC presented here provides a framework for
probing the effects of amino acid substitutions that lead
to molybdenum cofactor deficiency in humans. 
Results and discussion
The polymerase chain reaction (PCR) was used to clone the
sequence encoding the MoaC protein from a plasmid carry-
ing the entire moa operon. During cloning, three discrepan-
cies between the plasmid and the published nucleotide
sequence were observed which altered the predicted amino
acid sequence of MoaC [20]. Subsequently, these substitu-
tions have been confirmed by sequence analysis of genomic
E. coli DNA (MMW and KVR, unpublished observations)
[21]. The corrected amino acid sequence of MoaC is shown
in Figure 1b. Homologous expression of the moaC gene and
protein purification were carried out as described in the
Materials and methods section. Wild-type MoaC and the
D128A variant were purified to greater than 98% homo-
geneity, typical protein yields were 20–40 mg/L of culture.
The crystal structure of MoaC was solved by multiple iso-
morphous replacement (MIR) using a hexagonal crystal
form (Tables 1 and 2). The structure has been refined at
2 Å resolution to a crystallographic R factor of 0.219 and an
Rfree of 0.252 (Table 2). The final model comprises
residues 11–148 and 152–156. Residues near both termini
(1–10 and 157–161) and in the loop following β strand 4
(residues 149–151) appear to be disordered and display no
electron density. The overall quality of the model is good
as judged by the low Rfree value, the low deviations from
stereochemical ideality, and the appearance of the
Ramachandran diagram. According to an analysis with the
program PROCHECK [22], 86.7% of the residues were
found in the most favored regions of the Ramachandran
diagram. Ala22 is located in a disallowed region and Arg48
in a generously allowed region; both of these residues are
located in highly flexible regions of the polypeptide.
Although the MoaC crystals diffract X-rays to about 2 Å
resolution, the molecule appears to be rather flexible as
indicated by the high temperature factors of the refined
model. Most notably, residues 11–25 and 152–156 have
average thermal displacement factors above 100 Å2. Nev-
ertheless, the electron density is sufficiently well defined
to follow the trace of the mainchain. Another highly
mobile region (residues 47–50) is located in the loop
between helices α1 and α2. Allowing the B factors to
refine to values greater than 100 Å2 leads to a reduction in
the Rfree compared to alternative refinement protocols in
which either an upper limit of 100 Å2 is enforced or these
highly mobile regions are omitted from the model. The
average thermal displacement factor for all atoms includ-
ing the mobile regions is quite high (71.3 Å2); this is
reduced to 64.4 Å2 if the mobile regions mentioned above
are excluded. In comparison, the average B factor as esti-
mated from the Wilson plot is considerably lower (48 Å2). 
Each MoaC monomer has an α+β structure and is com-
posed of a four-stranded antiparallel β sheet with two large
(α2 and α4) and two small (α1 and α3) helices, all located
on the same side relative to the β sheet (Figure 2). The
overall dimensions of the elongated molecule are
55 × 20 × 25 Å. Ignoring the two shorter α helices, the
MoaC structure can be described as being composed of
two inter-digitated β-α-β units with β1, α2 and β3 forming
one unit, and β2, α4 and β4 forming the second. According
to the classifications in the SCOP database [23] the fold of
MoaC belongs to the ferredoxin-like family. The two addi-
tional helices not typically present in a prototypical ferre-
doxin-like molecule are located immediately prior to and
following α2. Although helix α2 leads directly into α3, the
two helices intersect each other at an angle of 120°. The
discontinuity between the two helices appears to be impor-
tant for the oligomerization of MoaC (see below). MoaC
contains two cis peptides, Gly47 and Pro141. Gly47 is
located in the loop connecting α1 and α2. Pro141 forms a 
β bulge in strand β4 and is in close proximity to the twofold
axis of the dimer. A search for structural homologs of MoaC
using the program DALI [24] revealed a rather large
number of related structures. Searching with the monomer,
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Table 1
Data collection statistics.
Nat-1 Nat-2 EMTS PIP D128A
Resolution limits (Å) 50–2.1 50–2.0 50–2.8 50–3.0 50–2.5
Completeness 0.998 (0.970) 0.957 (0.979) 0.974 (0.984) 0.995 (0.975) 0.971 (0.986)
Mean redundancy 6.9 5.2 4.1 5.1 3.4
Rsym* 0.048 (0.387) 0.063 (0.365) 0.055 (0.403) 0.073 (0.603) 0.071 (0.516)
<I/σI>† 22.1 (3.5) 29.1 (3.5) 16.6 (2.4) 13.7 (1.9) 13.0 (1.9)
*Rsym = ΣhklΣi |Ii – <I>| / Σi <I>, where Ii is the ith measurement and <I> is the weighted mean of all measurements of I. †<I/σI> indicates the average
of the intensity divided by its standard deviation. Numbers in parentheses refer to the respective highest resolution data shell in each data set.
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the highest structural similarity is observed with the NAD-
binding domain of 3-hydroxy-3-methylglutary-coenzyme A
reductase (112 equivalent residues superimpose with a root
mean square [rms] deviation of 4.6 Å). 
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Table 2
Multiple isomorphous replacement and refinement statistics.
Nat-1 EMTS PIP Nat-2 D128A
Maximum resolution (Å) 2.8 2.8 3.0
Number of sites 2 (1 major) 1
Phasing power* 2.65 (0.92) 0.89 (0.57)
RCullis† 0.562 (0.545) 0.774 (0.843)
Mean figure of merit 0.405¥ 
Resolution limits (Å) 20.0–2.0 20.0–2.5
Number of reflections 9352 5098
Number of protein/solvent atoms 1103/41 1070/14
R (Rfree)‡ 0.219 (0.252) 0.217 (0.276)
Deviations from ideal values
bond distances (Å) 0.007 0.008
angle distances (Å) 0.025 0.030
1,4 distances (Å) 0.030 0.042
chiral volumes (Å3) 0.099 0.109
torsion angles (°)§ 3.4/19.6/36.7 3.3/21.4/26.1
Ramachandran statistics (%)# 86.7/11.7/0.8/0.8 85.6/12.8/1.6/0.0
*Phasing power is the mean value of the heavy-atom structure-factor
amplitude divided by the lack of closure for isomorphous differences of
acentric data (anomalous differences are given in parentheses). †RCullis
is the lack of closure divided by the absolute value of the difference
between FPH and FP the structure factors of the heavy-atom derivative
and native crystal, respectively, for isomorphous differences of acentric
data (centric data given in parentheses). ‡R = Σ||Fo|–|Fc||/Σ|Fo|, where
Fo and Fc are the observed and calculated structure-factor amplitudes.
Rfree same as R calculated for 10% of the data randomly omitted from
the refinement. The number of reflections excludes the Rfree subset.
§Torsion angle deviations are given separately for planar, staggered
and orthonormal conformations. #Ramachandran statistics indicate the
fraction of residues in the most favored, additionally allowed,
generously allowed, and disallowed regions of the Ramachandran
diagram as defined by PROCHECK. ¥For all data to 2.8 Å resolution.
Figure 2
Structure of the MoaC monomer. (a) Stereoview Cα trace of the
MoaC monomer. The terminal residues and every twentieth residue are
labeled. (b) Ribbon diagram of the MoaC monomer viewed
perpendicular to the central β sheet. β Strands are shown as magenta
arrows, α helices as cyan ribbons and loop regions are in yellow.
Secondary structure elements, the N and C termini and the residues
adjacent to the disordered loop are labeled. This figure was produced
using the programs Molscript [47] and Raster3D [48].
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In its functional state, MoaC is a hexamer with 32 symme-
try generated by crystallographic symmetry operations in
the hexagonal lattice (Figure 3a). According to analytical
ultracentrifugation studies, the solution molecular weight
of the protein is 104.5 kDa, a value entirely consistent with
a hexameric arrangement of a 17,218 Da protein. Within
the hexamer, each monomer contacts all other monomers,
but the majority of interactions are within the dimer and to
a smaller degree within the trimer. The dimer is formed by
the three-layer arrangement of secondary structure ele-
ments shown in Figure 3b. On the outside of the dimer, an
antiparallel interaction of the β4 strands creates an eight-
stranded antiparallel β-sheet with a convex surface. All
helices are located underneath the β sheet and are
arranged in two additional layers. The central layer is gen-
erated by the C-terminal helices (α4), whereas helices two
and three form the bottom layer. The discontinuity
between helices α2 and α3 appears necessary to bring
helix α3 of one monomer into contact with the N-terminal
region of helix α2 of the second molecule in the dimer.
The majority of the monomer–monomer interactions are
contributed by two discontinuous regions in the polypep-
tide chain: residues 47–76 (helices α2 and α3) and residues
112–147 (helix α4 and strand β4). In total, 22% of the mol-
ecular surface of the monomer is buried upon dimeriza-
tion. One third of the dimer interface consists of polar
atoms, which form eight intersubunit hydrogen bonds.
The remainder of the interface is comprised of apolar
atoms. The interactions within the trimer bury a total of
18% of the monomer accessible surface and are equally
distributed among two interaction surfaces. Residues
10–19 and 70–80 contribute to one interface, whereas
residues 53–70 and 78–87 are involved in the second inter-
face. In total, 42% of the accessible surface of each
monomer is buried in the hexamer. Compared to other
oligomeric proteins [25] this is an unusually high fraction,
implying that the hexamer is a very stable structure. 
An analysis of the sequence conservation among 18 MoaC
proteins from different organisms, including eubacteria,
archaea and eukaryotes, in the context of the three-dimen-
sional structure of MoaC suggests that a region at each end
of the dimer is of functional importance (Figures 4a,b).
This putative active site is located at the dimer interface
and generated by α4 and two loop regions from one
monomer together with one loop region from the second
monomer. Four sequence stretches are involved in the for-
mation of the active site (Figure 4c): residues 71–78, which
form the loop between α3 and β2 (helix α3 directly leads
into a β turn, residues 73–76, with the strictly conserved
Pro74 at the i+1 position); residues 108–114 in the loop that
precedes α4 and the first helical turn of α4; residues 128
and 131 near the C-terminal end of α4; and Lys51, located
in the loop between helices α1 and α2. In addition, the
strictly conserved Lys67 residue from a third monomer
appears to be crucial for the conformation of one of the
active-site loops, particularly the tight β turn following α3.
The terminal amino group of this lysine is involved in three
strong (2.7 Å average distance) hydrogen bonds to the
mainchain carbonyl groups of residues 70, 74 and 76 result-
ing in an approximately threefold symmetrical arrangement
of the Nζ atom of Lys67 and the carbonyl oxygen atoms.
The view of the molecular surface (Figure 4b) also reveals
the existence of a pocket in the surface of this region. The
pocket is of sufficient size to accommodate a guanosine
derivative, precursor Z or other unknown intermediates of
similar size possibly occurring during the first step of Moco
biosynthesis. Located within this pocket is the area with
the highest degree of sequence conservation, including the
strictly conserved residues Lys51, His77, Glu112, Glu114,
Asp128 and Lys131. Although electrostatic calculations
reveal an approximately equal distribution of positively and
negatively charged regions on the MoaC surface (reflecting
the calculated pI of 6.6), there is an uneven distribution of
charges in the putative active-site region. Whereas the
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Figure 3
Oligomerization of MoaC. (a) Ribbon diagram
of the MoaC hexamer viewed along the
threefold axis. Each color represents a
different monomer. (b) The MoaC dimer
viewed perpendicular to its dyad axis. One
monomer is colored in magenta the other in
cyan. The C-terminal α4 helices are located in
the center of the molecule and are completely
surrounded by additional secondary structure
elements. This figure was produced using the
programs Molscript [47] and Raster3D [48].
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bottom of the pocket is negatively charged, the walls of the
pocket are predominantly positively charged (data not
shown). As it is likely that the MoaC substrate contains a
terminal phosphate, this positively charged area could serve
to stabilize this portion of the substrate. 
In order to characterize whether the residues mentioned
above are crucial for MoaC function, the ability of plasmids
expressing MoaC variants to complement a moaC– strain
was assessed. The moaC gene is located within the moa
operon. This operon contains the genes encoding the MoaA
and MoaC proteins as well as the small and large subunits of
MPT synthase (MoaD and MoaE, respectively). Currently,
the only available E. coli moaC– strains have been generated
by Mu insertion mutagenesis [20,26]. Since Mu insertion
has a polar effect on gene expression and the start site for
the moaD gene overlaps the end of the moaC gene by eight
base pairs [20], these moaC– strains are also moaD– [27]. In
order to restore cofactor biosynthesis activity to such a
strain, both the moaC and moaD genes must be present.
Accordingly, PCR was used to generate the expression
plasmid pMW15aC/D with an insert that contains the moaC
and moaD genes as they appear in the E. coli genome. Using
pMW15aC/D, several site-directed, single amino acid sub-
stitutions of MoaC were generated: these include replace-
ment of Thr117 with a proline and replacement of the
highly conserved residues Lys51, Gly52, Lys67, Cys76,
His77, Gly110, Glu112, Asp128 and Lys131 with alanine. 
The nitrate reductases are Moco-containing enzymes and
their activity permits cells to utilize nitrate as the terminal
electron acceptor under anaerobic conditions. Comple-
mentation of the moaC::Mucts strain, RK5245(DE3), with
functional copies of both moaC and moaD should restore
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Figure 4
The putative active site of MoaC. (a) Stereoview Cα trace of the dimer
viewed along the twofold axis of symmetry. Within the dimer, two
active sites are located at opposite ends of the elongated molecule.
Active-site loops and conserved polar sidechains are shown in yellow
with oxygen atoms in red and nitrogen atoms in blue. (b) The level of
sequence conservation among 18 different MoaC proteins. The
degree of sequence conservation is mapped onto the molecular
surface of the MoaC dimer. Conserved regions are indicated in
magenta and cyan for the different monomers, with higher saturation
corresponding to higher conservation. Gray areas represent lower
levels of sequence conservation. This view is related to Figure 3b by a
~25° rotation around the horizontal axis. This figure was generated
with SPOCK [49]. (c) Stereoview representation of an expanded view
of the putative active site. Selected regions of the two monomers are
shown in magenta and cyan, respectively. The additional monomer
harboring Lys67 is shown in green. All backbone atoms of residues
70–76 are shown and hydrogen bonds are indicated as dotted lines.
The sidechains of selected residues are shown and are labeled in
single-letter amino acid code. Parts (a) and (c) were produced using
the programs Molscript [47] and Raster3D [48].
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nitrate reductase activity to these cells. This strain was
complemented with the wild-type or mutant forms of
pMW15aC/D, and the resulting cells were grown anaero-
bically on nitrate-containing medium. As shown in
Figure 5a, complementation with the T117P and D128A
variants of MoaC resulted in little or no nitrate reductase
activity, as growth of these cells after 12 h was similar to
that of the uncomplemented parent strain. The cells that
were complemented with the remaining eight MoaC vari-
ants were capable of anaerobic growth on nitrate. In all
cases, however, this growth was less than 60% of that sup-
ported by the wild-type plasmid, indicating that the muta-
tions had impaired the activity of the expressed MoaC
protein to varying degrees. These results further support
the assignment of the putative active site of MoaC to the
region highlighted in Figure 4. More importantly, they
suggest an important role in MoaC activity for Asp128 and
confirm the deleterious effects of the human point muta-
tion, which corresponds to the T117P substitution. 
The crystal structure of the D128A variant of MoaC has
been refined at 2.5 Å resolution to an R factor of 0.217
(Rfree = 0.276). Although this variant could only be crystal-
lized under conditions different from those employed for
the wild-type protein, the mutant crystals still belong to the
same hexagonal space group with closely related cell
dimensions. Compared to the wild-type structure, surpris-
ingly large conformational changes were observed for
residues 47–51 in the loop between helices α1 and α2
(Figure 5b). Including the Cα atoms of all residues, the rms
deviation after superposition of the two structures is 1.7 Å
with maximum displacements of 11.5 Å and 9.9 Å for His49
and His50, respectively. Omitting residues 47–51, the two
structures are almost identical as reflected by an rms devia-
tion of 0.4 Å after superposition. In the structure of the
wild-type protein, the strictly conserved Lys51 residue in
the flexible loop points into the active site and its terminal
nitrogen atom is 2.7 Å from one of the carboxylate oxygens
of Asp128. In the D128A variant this interaction is elimi-
nated and Lys51 is solvent-exposed and highly flexible. In
the variant, a pronounced density feature linked to the
sidechain of His77 and extending towards Lys131 of the
adjacent monomer could be located in the putative active
site. This feature has been tentatively modeled as tartrate
owing to its presence in the crystallization buffer. The
bound tartrate seems to induce minor structural changes in
some of the residues in the putative active site, such as
His77 and Lys131, but the mainchain conformation at the
site of the mutation is unaffected. On the other hand, the
bound tartrate does not appear to be responsible for the
conformational change involving residues 47–51, as Lys51
in the orientation observed in the wild-type protein should
be able to favorably interact with the tartrate.
Thr117 is located in helix α4, six residues from its 
N terminus, in close vicinity to the active-site pocket. 
Substitution of this residue with proline causes Moco
deficiency in humans [12]. This residue is highly con-
served among different MoaC proteins (Figure 1b). The
reason for the dramatic effects of this substitution could
be either a general destabilization of the protein or a per-
turbation of the putative active site. Although insertion
of proline residues into α helices generally leads to a
destabilization [28,29], proteins are sometimes able to
tolerate these substitutions quite well [30]. Large struc-
tural effects of these types of substitutions have also
been observed; for instance, a leucine to proline substi-
tution in an α helix of ferritin leads to both the unfolding
of the helical segment N-terminal to the proline as well
as unfolding of the C-terminal segment of the preceding
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Figure 5
Properties of MoaC variants. (a) Anaerobic growth of complemented
RK5245(DE3) strains on nitrate. The optical density at 600 nm of the
cultures was measured directly in the tubes after 12 h of growth. Column
heights indicate the average values and standard deviations of four
different growths after subtracting the optical density of the parent strain.
(b) Structural changes in the D128A variant. Superposition of the dimer
of the D128A variant (magenta and cyan) and the wild-type protein
(gray) in the vicinity of the active-site region. The bound tartrate (Tar) and
selected residues are shown (labeled in single-letter amino acid code).
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helix and the connecting loop [31]. To analyze the
effects of the T117P substitution in MoaC, we have
introduced a proline at this position in vivo and have
assayed for MoaC function by biochemical methods.
Figure 5a indicates that this mutation severely decreases
the activity of the expressed protein. In addition, we
have attempted to overexpress and purify the T117P
variant of MoaC. In contrast to the wild type and the
D128A variant, the protein was expressed in an insoluble
form and could not be purified. These results indicate
that this point mutation leads to large structural changes.
Introduction of the proline residue into helix α4 might
disrupt the dimer interface, thus affecting the oligomeric
state of MoaC and negatively influencing protein
folding. Two additional mutations have been identified
in the human mocs1B gene [12], but these lead to
frameshift mutations near the N terminus of the protein
and yield severely altered proteins.
Together with MoaA, MoaC is involved in the first step
of Moco biosynthesis, namely the conversion of a guano-
sine derivative to precursor Z. Labeling studies have
revealed that the carbon atom at position 8 of the
guanine is incorporated into the pyran ring of the tri-
cyclic pyranopterin. This is different from all other
pterin biosynthetic pathways in which this carbon is
usually eliminated as formate [32]. Overall, the first step
of Moco biosynthesis appears to involve a rather sophis-
ticated rearrangement reaction. At present it is unclear
whether MoaA and MoaC act independently of each
other or form a protein–protein complex. The human
orthologs (MOCS1A and MOCS1B) of MoaA and MoaC
are encoded by a bicistronic mRNA [11]. A bicistronic
mRNA has also been detected for the two subunits
(MOCS2A and MOCS2B) of human MPT synthase [13].
These findings are surprising as bicistronic mRNA is
rather infrequently encountered in humans. As MPT
synthase is a heterodimer consisting of a large and a
small subunit, a tight regulation of the stoichiometries of
the two subunits would appear to be desirable. Conse-
quently, it is tempting to speculate that MOCS1A and
MOCS1B and their E. coli counterparts MoaA and MoaC
also form protein–protein complexes. Given the stable
association of MoaC into a hexamer, binding of MoaA
would be more likely to occur onto the preassembled
MoaC hexamer. This interaction could also lead to the
stabilization of some of the flexible regions in the MoaC
protein. MoaA contains an iron–sulfur cluster [33] and
shows sequence similarities to a variety of proteins
including biotin synthase, pyruvate formate lyase, and
anaerobic ribonucleotide reductase. The similarity to
these proteins might indicate that the early steps in
Moco biosynthesis  involve a radical-based mechanism.
One putative function of MoaC in this context could be
to utilize an adenosyl radical generated by MoaA and
produce a more stable glycyl radical, in analogy to the
anaerobic ribonucleotide reductase system [34] and
pyruvate formate lyase [35]. In the anaerobic ribonu-
cleotide reductase from bacteriophage T4, the radical is
located at Gly580 and substitution of this residue with
alanine leads to a 360-fold reduction in enzyme activity
[34]. Two glycine residues at positions 52 and 110 are
among the strictly conserved residues in MoaC. Substi-
tution of either glycine by alanine leads to only a minor
reduction in cofactor biosynthesis (Figure 5a), refuting
the hypothesis that MoaC harbors a stable glycyl radical. 
Biological implications
The Molybdenum cofactor (Moco) is found in a large
family of enzymes that catalyze important transforma-
tions in carbon, nitrogen and sulfur metabolism. Moco
biosynthesis is an evolutionarily conserved pathway
present in all phyla. In humans, xanthine dehydrogenase,
aldehyde oxidase and sulfite oxidase require Moco for
activity. Defects in the enzymes involved in Moco biosyn-
thesis as well as point mutations in the gene encoding
sulfite oxidase lead to severe neurological symptoms and
premature death in humans. The MoaC protein, together
with MoaA, is involved in the first step of Moco biosyn-
thesis in which a guanosine derivative is converted into
precursor Z. MOCS1A and MOCS1B, the human
orthologs of MoaA and MoaC, respectively, display signif-
icant sequence similarities with the Escherichia coli pro-
teins and are expected to have closely related
three-dimensional structures.
We describe here the purification, characterization,
and crystal structure of E. coli MoaC at 2 Å resolution.
Although the crystal structures of a number of Moco-
containing enzymes have been reported recently,
MoaC is only the second protein involved in Moco
biosynthesis for which a three-dimensional structure is
now available. The limited number of conserved
residues present in MoaC orthologs and their occur-
rence in a confined area in the three-dimensional
structure allowed the identification of a putative active
site. The importance of several of these conserved
residues was probed by site-directed mutagenesis. All
of these replacements reduced protein activity to some
extent, but substitution of Asp128 with alanine ren-
dered the protein almost completely inactive. Replace-
ment of a conserved threonine with proline leads to
Moco deficiency in humans and the corresponding
T117P variant of E. coli MoaC has significantly
reduced activity. In contrast to the wild-type protein
and the D128A variant, the T117P variant is
expressed in an insoluble form indicating substantial
structural changes which could potentially interfere
with oligomerization of MoaC into its active hexameric
state. The structure of MoaC presented here will
provide valuable insights into the molecular basis for
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the loss of function associated with additional muta-
tions in human MOCS1B that lead to Moco deficiency. 
Materials and methods
Cloning, expression and purification of MoaC
The gene encoding E. coli MoaC was cloned by PCR from pSJE100, a
plasmid containing the entire moa operon. Using the published
sequence for the plasmid [20], PCR primers were designed to allow
for cloning into the Nco I and Bam HI sites of the multiple cloning
region of the pET 15b expression vector (Novagen) to generate
plasmid pMW15aC. A second plasmid, pMW15aC/D, was generated
by the same method. In this plasmid, the contiguous coding regions for
both MoaC and MoaD are arranged exactly as they appear in the
genomic DNA. In the course of both cloning procedures, the second
amino acid of MoaC was changed from serine to alanine. 
For expression of MoaC, 1 l cultures of BL21(DE3) cells carrying
pMW15aC were induced by the addition of 0.1 mM IPTG when the
cells had reached an A600 of 0.6. After 4 h of growth at 30°C, cells
were harvested and resuspended in 10 ml of 50 mM Tris, 2 mM
EDTA (pH 8.0) and frozen at –20°C. All buffers used for subsequent
purification steps consisted of 50 mM Tris, pH 8.0, with additional
components as indicated. The thawed cell suspension was passed
twice through a French pressure cell. After centrifugation at
17,000 × g, the volume of the clarified extract was increased to
400 ml with suspension buffer. Nucleic acids were precipitated by
the addition of 44 ml of 20% (w/v) streptomycin sulfate and removed
by centrifugation. Solid ammonium sulfate (390 g/l) was slowly
added to the cold supernatant, which was then centrifuged at
10,000 × g for 10 min before addition of a second aliquot of 55 g/l of
ammonium sulfate. After centrifugation, the pellet was suspended
and dialyzed overnight against a buffer containing 50 mM NaCl.
The sample was applied to a Q-Sepharose column, and MoaC was
eluted with a linear gradient of 0.1–0.45 M NaCl. This and subsequent
chromatography steps were performed using an Amersham Pharmacia
Biotech fast protein liquid chromatography (FPLC) system. Fractions
containing MoaC were pooled and dialyzed overnight. Prior to injection
onto a phenyl-Sepharose column, the sample was brought to 20% sat-
uration with ammonium sulfate, and MoaC was eluted from the column
with a 20–0% saturated ammonium sulfate gradient. After concentra-
tion, the protein was chromatographed on a Superose 12 column equi-
librated with a buffer containing 50 mM NaCl. Fractions containing
pure MoaC were pooled and concentrated to 12–15 mg/ml prior to
dialysis against H2O. 
Site-directed mutagenesis and activity of MoaC proteins
The transformer site-directed mutagenesis kit from Clontech was
employed to generate the following MoaC single amino acid substitutions
in plasmid pMW15aC/D: K51A, G52A, K67A, C76A, H77A, G110A,
E112A, T117P, D128A and K131A. The D128A and T117P mutations
were similarly generated in pMW15aC. Nucleic acid sequences were ver-
ified by manual or automated sequencing of both strands. 
With the aid of the λ DE3 lysogenization kit from Novagen, the T7
RNA polymerase gene was integrated into the chromosome of the
E. coli MoaC– strain RK5245 [26] to generate RK5245(DE3). The
wild type and ten mutated versions of pMW15aC/D were transferred
individually into this strain. Anaerobic growth on nitrate was
assessed using PN media [26] containing 0.2% glycerol, 25 µg/ml
streptomycin sulfate, 2 µg/ml thiamine, 1 µg/ml nicotinic acid,
40 ng/ml biotin, and 1 µl/ml of the trace element solution for Vogel’s
medium N [36]. The uncomplemented and 11 complemented
RK5245(DE3) strains were cultured for 16 h at 30°C in streptomycin
sulfate-supplemented LB medium. The cells from a 100 µl aliquot of
each culture were pelleted, and the media removed. After resuspen-
sion in 50 µl of PN medium, the cell aliquots were transferred into a
Coy anaerobic chamber and used to inoculate individual 4 ml cul-
tures of PN medium. The cultures were then rotated continuously on
a Nutator from Adams. After 12 h of growth at ambient temperature,
the tubes were removed from the chamber, and the OD600 of the cul-
tures was recorded using a Shimadzu 1601 spectrophotometer. 
Crystallization and structure determination
MoaC was crystallized by vapor diffusion of a 10 mg/ml protein solution in
H2O against a reservoir solution containing 28% PEG 400 and 0.2 M
CaCl2 in 0.1 M HEPES (pH 7.5). Hexagonal rods that belong to space
group P6322 with a = 91.1 Å and c = 62.7 Å were obtained within a few
days. The crystals contain one monomer in the asymmetric unit yielding a
Matthew’s coefficient of 2.1 Å3/Da, which corresponds to a solvent
content of 42%. The structure of MoaC was solved by multiple isomor-
phous replacement using a Hg derivative (1 mM ethylmercurythiosalicylate
[EMTS]) and a Pt derivative (1 mM di-µ-iodobis(ethylenediamine)diplat-
inum nitrate [PIP]). Initial native (NatL) and derivative data sets were col-
lected to resolutions of 2.8 Å (Nat1), 2.8 Å (EMTS) and 3.0 Å (PIP) from
cryocooled crystals on a Rigaku RU 200 rotating-anode X-ray generator
equipped with double focussing mirror optics and an R-axis II imaging
plate detector. Subsequently, a 2 Å data set was collected on beamline
X26C at the National Synchrotron Light Source (NSLS) at Brookhaven
National Laboratory with a MarResearch 300 mm imaging plate detector
at a wavelength of 1.1 Å. All data sets were indexed, integrated and
scaled with the HKL software [37]. For subsequent calculations, the
CCP4 suite was used with exceptions as indicated [38]. The EMTS deriv-
ative was solved by Patterson methods and direct methods using SHELX
[39], and the PIP derivative was solved by difference Fourier calculations. 
Phase refinement was performed with SHARP [40] to a resolution of
2.8 Å followed by solvent flattening with SOLOMON [41]. The result-
ing electron-density map was of reasonable quality and a preliminary
model was built with the program O [42]. After a first round of torsion
angle dynamics refinement with X-PLOR [43] at 2.8 Å resolution,
model phases and experimental phases were combined and a few
additional residues could be located. Several rounds of refinement
using X-PLOR yielded a preliminary model (R = 0.248 and
Rfree = 0.294) comprising residues 20–159. At this stage, the 2 Å reso-
lution data set was collected and refinement against the new data set
was performed using a combination of the programs X-PLOR and
REFMAC [44]. All data (no σ cutoff) between 20 Å and the high-resolu-
tion limit were included in the refinement and partial structure factors
for the bulk-solvent contribution were calculated in X-PLOR. Weak
density was observed for residues 11–19, which were added to the
model. At the same time, residues 149–151 and 157–159 were
omitted from the model owing to the lack of electron density. 
The D128A variant of MoaC could not be crystallized under the same
conditions as the wild type, but instead was crystallized from
1.7–2.1 M (NH4)2HPO4 and 0.05–0.1 M K,Na tartrate in 0.1 M citrate
buffer (pH 5.6). The crystals belong to the same space group with
related unit-cell dimensions (a = 92.1 Å and c = 63.3 Å). A 2.5 Å data
set was collected on beamline X26C at room temperature. Radiation-
induced damage led to a rapid decay in diffraction quality limiting the
resolution to 2.5 Å and allowing collection of only 19° of usable data.
Refinement followed a similar protocol as for the wild type. Within the
common resolution range, the same set of reflections was used for cal-
culations of the free R factor. After the first round of refinement,
residues 11–14 and 47–53 were omitted from the refinement owing
to a complete lack of electron density. After torsion angle dynamics
refinement in X-PLOR, continuous density was observed for residues
47–53 in a different location than in the wild type. In the new confor-
mation, these residues partially overlap with residues 11–14 in the
wild type, which could not be located in the D128A variant.
Accession numbers
Coordinates for wild-type MoaC and the D128A variant have been deposited
in the Protein Data Bank, with accession codes 1EKR and 1EKS, respectively.
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